News

Zacks Investment Research on MSN1h
GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug
GSK plc GSK announced that it has signed an agreement with Massachusetts-based biopharmaceutical company Boston ...
iTeos Therapeutics: End To Belrestotug Program Leads To A Hold Rating
Teos Therapeutics downgraded to Hold after belrestotug failure and GSK deal ending. Read my updated analysis on ITOS stock ...
Applied Clinical Trials Online20h
iTeos and GSK Halt TIGIT Antibody Belrestotug Development After Phase II Trials Miss Efficacy Marks in NSCLC and HNSCC
Decision follows underwhelming Phase II results from GALAXIES Lung-201 and H&N-202 trials, prompting iTeos and GSK to end ...